Blog Post by Admin
Blog
Dec 20, 2019
Let’s talk about value: How biopharma can maximize utility of RWE in value discussions
With the drug pricing pressures mounting on a global scale, there is a clear and imminent ...
Start Reading
Blog
Dec 14, 2019
Ask our experts: Working with real world data sets: What types of questions can your data answer?
The promise of real-world evidence (RWE) comes with a steep learning curve. As regulators ...
Start Reading
Blog
Dec 6, 2019
Advancing cancer care with real-world data: Next steps for collaborators
In oncology, over 90 percent of patient treatment experiences occur outside of clinical ...
Start Reading
Blog
Nov 23, 2019
Evidence at the Apex: Five learnings from the first annual Aetion Summit
Last month, the inaugural Aetion Summit in New York City brought together some of the ...
Start Reading
Blog
Nov 21, 2019
Learnings from three FDA decisions on ECA submissions in oncology
The publication of the Framework for FDA’s Real-World Evidence Program nearly a year ago ...
Start Reading
Blog
Nov 15, 2019
Spotlight on trust and transparency at ISPOR Europe 2019
The digital age has transformed the amount and quality of data available and given rise ...
Start Reading
Blog
Nov 8, 2019
Bold moves in RWE — from FDA, industry, and tech at HLTH 2019
Two weeks ago, researchers at NYU published new findings on how objects move against a ...
Start Reading
Blog
Oct 30, 2019
RWE advances amidst “data tsunami”: Takeaways from FOCR 8th Annual Blueprint for Breakthrough Forum
Breakthroughs in data extraction and analysis coupled with federal infrastructure ...
Start Reading
Blog
Oct 25, 2019
FDA’s Technology Modernization Action Plan: Three ways to prepare for the coming RWE infrastructure
The U.S. Food and Drug Administration (FDA) recognizes that common standards and a shared ...
Start Reading
Blog
Oct 12, 2019
The case for real-world evidence in health technology assessment
New drugs are launched based on data from randomized controlled trials (RCTs), the gold ...
Start Reading
Presentation
Oct 4, 2019
An Introduction to Synthetic Clinical Trial Data
Start Reading
Blog
Oct 4, 2019
On FHIR: How “Fast Healthcare Interoperability Resources” will improve real-world data quality
In 2009, health care data entered the digital age with the HITECH Act and the ...
Start Reading
Blog
Sep 27, 2019
Everyone in the pool: How diverse stakeholders speed RWE adoption
A recent issue of Clinical Pharmacology & Therapeutics focused entirely on real-world ...
Start Reading
Blog
Sep 20, 2019
Takeaways from the 35th ICPE
At the end of August, pharmacoepidemiology enthusiasts from across the globe gathered in ...
Start Reading
Blog
Sep 12, 2019
What can electronic health records tell us—and how? Q&A with Andrew Bate, Ph.D.
As pharma manufacturers and regulatory agencies increase the role of real-world data ...
Start Reading
Blog
Aug 30, 2019
Know your database—and its culture: Working with global real-world databases
Health care databases are not created in a vacuum. They represent patients—people—and ...
Start Reading
Blog
Aug 20, 2019
The case for real-world evidence in Germany
A recently published study in the British Medical Journal by Wieseler et al. of the ...
Start Reading
Blog
Jul 26, 2019
Writing the perfect cover letter: A look at the FDA’s forthcoming guidance on submitting RWE studies
In May 2019, the U.S. Food and Drug Administration (FDA) released a draft guidance that ...
Start Reading
Blog
Jun 25, 2019
Predicting the CAROLINA trial with real-world evidence: Three takeaways for pharma
The U.S. Food and Drug Administration has long relied on randomized controlled trials ...
Start Reading
Blog
Jun 21, 2019
Reproductive health and opioids: How real-world evidence reveals patients’ stories
Research conducted using real-world data (RWD) in recent years has increased our ...
Start Reading
Blog
Jun 14, 2019
Addressing the determinants of health: What is pharma’s role?
As recognition grows that health care is broader than medical care, innovative ...
Start Reading
Blog
Jun 7, 2019
How real-world evidence supports outcomes-based care and contracting: A conversation with Saira Jan, Pharm.D., Horizon BCBSNJ
As the applications of real-world evidence (RWE) in pharmaceutical manufacturing expand, ...
Start Reading
Blog
May 31, 2019
Health Canada moves to adopt real-world evidence
On April 16, 2019, Health Canada announced a new position to leverage real-world evidence ...
Start Reading
Blog
May 24, 2019
Four takeaways from ISPOR 2019
At the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR) 24th ...
Start Reading